World Orphan Drug Congress (WODC)

Don’t miss our panel

Discovery 1-2-3. Three Biotech Companies Share How They are Using Genomic Insights to Accelerate Drug Development.

  April 23, 2:50 pm

  Innovation & Partnership Track, Theater 2

We’re excited to host a dynamic panel discussion with our partners Sarepta Therapeutics, Stoke Therapeutics, and iECURE. Moderated by Amanda Singleton (GeneDx), this 40-minute session dives into the real-world impact of genomics on rare disease drug development.

During this panel, you’ll learn how:

• Genetic insights are reshaping drug development strategies in real time
• Biotech companies are using genomics to drive smarter, faster R&D
• Integrated datasets are accelerating therapeutic breakthroughs